US20170128403A1 - Compositions and methods for treating macular degeneration - Google Patents

Compositions and methods for treating macular degeneration Download PDF

Info

Publication number
US20170128403A1
US20170128403A1 US15/344,102 US201615344102A US2017128403A1 US 20170128403 A1 US20170128403 A1 US 20170128403A1 US 201615344102 A US201615344102 A US 201615344102A US 2017128403 A1 US2017128403 A1 US 2017128403A1
Authority
US
United States
Prior art keywords
retinal
trans
lipofuscin
retinoid
macular degeneration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US15/344,102
Inventor
Ilyas Washington
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Columbia University of New York
Original Assignee
Columbia University of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US99337907P priority Critical
Priority to US12/733,631 priority patent/US8877809B2/en
Priority to PCT/US2008/010676 priority patent/WO2009035673A1/en
Priority to US14/510,975 priority patent/US9486432B2/en
Application filed by Columbia University of New York filed Critical Columbia University of New York
Priority to US15/344,102 priority patent/US20170128403A1/en
Publication of US20170128403A1 publication Critical patent/US20170128403A1/en
Abandoned legal-status Critical Current

Links